Login / Signup

A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements.

Lisa FishMatvei KhoroshkinAlbertas NavickasKristle GarciaBruce CulbertsonBenjamin HänischSteven ZhangHoang C B NguyenLarisa M SotoMaria DermitFaraz K MardakhehHenrik MolinaClaudio R AlarcónHamed S NajafabadiHani Goodarzi
Published in: Science (New York, N.Y.) (2021)
Aberrant alternative splicing is a hallmark of cancer, yet the underlying regulatory programs that control this process remain largely unknown. Here, we report a systematic effort to decipher the RNA structural code that shapes pathological splicing during breast cancer metastasis. We discovered a previously unknown structural splicing enhancer that is enriched near cassette exons with increased inclusion in highly metastatic cells. We show that the spliceosomal protein small nuclear ribonucleoprotein polypeptide A' (SNRPA1) interacts with these enhancers to promote cassette exon inclusion. This interaction enhances metastatic lung colonization and cancer cell invasion, in part through SNRPA1-mediated regulation of PLEC alternative splicing, which can be counteracted by splicing modulating morpholinos. Our findings establish a noncanonical regulatory role for SNRPA1 as a prometastatic splicing enhancer in breast cancer.
Keyphrases
  • transcription factor
  • papillary thyroid
  • binding protein
  • squamous cell carcinoma
  • squamous cell
  • public health
  • childhood cancer
  • cell cycle arrest
  • young adults
  • cell death